(Q37981003)

26 August 2017

title

Review of Chinese clinical trials on CIK cell treatment for malignancies (English)

1 reference

26 August 2017

Xiao-Dong Li

1

1 reference

26 August 2017

Bin Xu

2

1 reference

26 August 2017

Jun Wu

3

1 reference

26 August 2017

Mei Ji

4

1 reference

26 August 2017

Bei-Hua Xu

5

1 reference

26 August 2017

Jing-Ting Jiang

6

1 reference

26 August 2017

Chang-Ping Wu

7

1 reference

26 August 2017

publication date

1 February 2012

1 reference

Clinical and Translational Oncology

26 August 2017

published in

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

102-108

1 reference

26 August 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Developments in clinical cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Cytokine-induced Killer Cells: NK-like T Cells with Cytotolytic Specificity against Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0768-4

Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells

21 January 2018

1 reference

12 December 2020

Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts

1 reference

12 December 2020

Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells.

1 reference

12 December 2020

Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma.

1 reference

12 December 2020

Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforin-dependent mechanisms

1 reference

12 December 2020

Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.

1 reference

12 December 2020

[Intratumoral injection of immature dendritic cells (DC) for cancer patients]

1 reference

12 December 2020

Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.

1 reference

12 December 2020

Graft-versus-Ewing sarcoma effect and long-term remission induced by haploidentical stem-cell transplantation in a patient with relapse of metastatic disease

1 reference

12 December 2020

Cytokine-induced NK-like T cells: from bench to bedside

1 reference

12 December 2020

10.1007/S12094-012-0768-4

Identifiers

DOI

1 reference

26 August 2017

1 reference